Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$16.46 - $17.44 $16,970 - $17,980
1,031 Added 2.33%
45,343 $764,000
Q4 2023

Feb 13, 2024

BUY
$14.32 - $16.57 $80,578 - $93,239
5,627 Added 14.55%
44,312 $734,000
Q3 2023

Nov 13, 2023

BUY
$15.52 - $17.49 $15,023 - $16,930
968 Added 2.57%
38,685 $601,000
Q1 2023

May 15, 2023

BUY
$16.86 - $19.02 $42,150 - $47,550
2,500 Added 7.1%
37,717 $665,000
Q4 2022

Feb 14, 2023

BUY
$17.4 - $19.47 $46,979 - $52,569
2,700 Added 8.3%
35,217 $633,000
Q2 2022

Aug 15, 2022

SELL
$17.53 - $21.84 $32,150 - $40,054
-1,834 Reduced 5.34%
32,517 $608,000
Q1 2022

May 09, 2022

BUY
$18.93 - $24.02 $174,610 - $221,560
9,224 Added 36.71%
34,351 $713,000
Q4 2021

Feb 01, 2022

BUY
$22.75 - $26.5 $571,639 - $665,865
25,127 New
25,127 $597,000

Others Institutions Holding HQH

About TEKLA HEALTHCARE INVESTORS


  • Ticker HQH
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund prim...
More about HQH
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.